These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9619835)

  • 1. PTEN mutations in gliomas and glioneuronal tumors.
    Duerr EM; Rollbrocker B; Hayashi Y; Peters N; Meyer-Puttlitz B; Louis DN; Schramm J; Wiestler OD; Parsons R; Eng C; von Deimling A
    Oncogene; 1998 Apr; 16(17):2259-64. PubMed ID: 9619835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
    Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
    Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
    Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
    Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
    Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
    Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
    Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
    Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
    Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.
    Forgacs E; Biesterveld EJ; Sekido Y; Fong K; Muneer S; Wistuba II; Milchgrub S; Brezinschek R; Virmani A; Gazdar AF; Minna JD
    Oncogene; 1998 Sep; 17(12):1557-65. PubMed ID: 9794233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
    Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
    Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
    Liu W; James CD; Frederick L; Alderete BE; Jenkins RB
    Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.
    Davies MP; Gibbs FE; Halliwell N; Joyce KA; Roebuck MM; Rossi ML; Salisbury J; Sibson DR; Tacconi L; Walker C
    Br J Cancer; 1999 Mar; 79(9-10):1542-8. PubMed ID: 10188904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
    Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
    Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.
    Zhou XP; Li YJ; Hoang-Xuan K; Laurent-Puig P; Mokhtari K; Longy M; Sanson M; Delattre JY; Thomas G; Hamelin R
    Int J Cancer; 1999 Apr; 84(2):150-4. PubMed ID: 10096247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the PTEN gene in human meningiomas.
    Peters N; Wellenreuther R; Rollbrocker B; Hayashi Y; Meyer-Puttlitz B; Duerr EM; Lenartz D; Marsh DJ; Schramm J; Wiestler OD; Parsons R; Eng C; von Deimling A
    Neuropathol Appl Neurobiol; 1998 Feb; 24(1):3-8. PubMed ID: 9549723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of malignant gliomas.
    Rasheed BK; Wiltshire RN; Bigner SH; Bigner DD
    Curr Opin Oncol; 1999 May; 11(3):162-7. PubMed ID: 10328589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression.
    Somerville RP; Shoshan Y; Eng C; Barnett G; Miller D; Cowell JK
    Oncogene; 1998 Oct; 17(13):1755-7. PubMed ID: 9796706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.
    Dong JT; Sipe TW; Hyytinen ER; Li CL; Heise C; McClintock DE; Grant CD; Chung LW; Frierson HF
    Oncogene; 1998 Oct; 17(15):1979-82. PubMed ID: 9788441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
    Fults D; Pedone C
    Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
    Tsao H; Zhang X; Benoit E; Haluska FG
    Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.